ADP-degrading enzymes inhibit platelet activation in bile duct-ligated rats

Journal of Thrombosis and Haemostasis

Volumn 8, Issue 2, 2010, Pages 360-368

  Witters, P ^a   Hoylaerts, M ^b   Freson, K ^b   De Vos, R ^a   Van Pelt, J ^a   Nevens, F ^a   Van Geet, C ^b   Cassiman, D ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

ADP; Cholestatic liver disease; Hemostasis; Phosphatase; Platelet function

Indexed keywords

ADENOSINE DIPHOSPHATE; ALKALINE PHOSPHATASE; APYRASE; BILE SALT; CHOLIC ACID; COLLAGEN; GLUTATHIONE; SCATTER FACTOR;

ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; CELL ULTRASTRUCTURE; CHOLESTASIS; CONTROLLED STUDY; ENZYME ACTIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SHAM PROCEDURE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; WISTAR RAT;

5'-NUCLEOTIDASE; ADENOSINE DIPHOSPHATE; ALKALINE PHOSPHATASE; ANIMALS; BILE DUCTS; BLOOD PLATELETS; CHOLESTASIS; COLLAGEN; DISEASE MODELS, ANIMAL; HUMANS; LIGATION; PLATELET AGGREGATION; PLATELET COUNT; RATS; RATS, WISTAR; TIME FACTORS;

EID: 74749083333     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2009.03684.x     Document Type: Article

References (31)

1. Lisman T, Leebeek FWG, de Groot PG. Haemostatic abnormalities in patients with liver disease. J Hepatol 2002, 37:280-7.
2. Caldwell S, Hoffman M, Lisman T, Macik B, Northup P, Reddy K, Tripodi A, Sanyal A. Coagulation disorders and hemostasis in liver disease: pathophysiology and critical assessment of current management. Hepatology 2006, 44:1039-46.
3. Witters P, Freson K, Verslype C, Peerlinck K, Hoylaerts M, Nevens F, van Geet C, Cassiman D. Review article: blood platelet number and function in chronic liver disease and cirrhosis. Aliment Pharmacol Ther 2008, 27:1017-29.
4. Pihusch R, Rank A, Göhring P, Pihusch M, Hiller E, Beuers U. Platelet function rather than plasmatic coagulation explains hypercoagulable state in cholestatic liver disease. J Hepatol 2002, 37:548-55.
5. Biagini MR, Tozzi A, Marcucci R, Paniccia R, Fedi S, Milani S, Galli A, Ceni E, Capanni M, Manta R, Abbate R, Surrenti C. Hyperhomocysteinemia and hypercoagulability in primary biliary cirrhosis. World J Gastroenterol 2006, 12:1607-12.
6. Atucha NM, Iyú D, Alcaraz A, Rosa V, Martínez-Prieto C, Ortiz MC, Rosado JA, García-Estañ J. Altered calcium signalling in platelets from bile-duct-ligated rats. Clin Sci 2007, 112:167-74.
7. Ingeberg S, Jacobsen P, Fischer E, Bentsen KD. Platelet aggregation and release of ATP in patients with hepatic cirrhosis. Scand J Gastroenterol 1985, 20:285-8.
8. Albornoz L, Bandi JC, Otaso JC, Laudanno O, Mastai R. Prolonged bleeding time in experimental cirrhosis: role of nitric oxide. J Hepatol 1999, 30:456-60.
9. Pereira J, Accatino L, Pizarro M, Mezzano V, Ibañez A, Mezzano D. In vivo effect of bile salts on platelet aggregation in rats. Thromb Res 1995, 80:357-62.
10. Bowen DJ, Clemmons RM, Meyer DJ, Dorsey-Lee MR. Platelet functional changes secondary to hepatocholestasis and elevation of serum bile acids. Thromb Res 1988, 52:649-54.
11. Laffi G, Marra F, Gresele P, Romagnoli P, Palermo A, Bartolini O, Simoni A, Orlandi L, Selli ML, Nenci GG. Evidence for a storage pool defect in platelets from cirrhotic patients with defective aggregation. Gastroenterology 1992, 103:641-6.
12. Laffi G, Cinotti S, Filimberti E, Ciabattoni G, Caporale R, Marra F, Melani L, Grossi A, Carloni V, Gentilini P. Defective aggregation in cirrhosis is independent of in vivo platelet activation. J Hepatol 1996, 24:436-43.
13. Rodríguez-Garay EA. Cholestasis: human disease and experimental animal models. Ann Hepatol 2003, 2:150-8.
14. Laleman W, Omasta A, Van de Casteele M, Zeegers M, Vander Elst I, Van Landeghem L, Severi T, van Pelt J, Roskams T, Fevery J, Nevens F. A role for asymmetric dimethylarginine in the pathophysiology of portal hypertension in rats with biliary cirrhosis. Hepatology 2005, 42:1382-90.
15. Akerboom TP, Sies H. Assay of glutathione, glutathione disulfide, and glutathione mixed disulfides in biological samples. Methods Enzymol 1981, 77:373-82.
16. Takahashi O. Characteristics of rat platelets and relative contributions of platelets and blood coagulation to haemostasis. Food Chem Toxicol 2000, 38:203-18.
17. Labarque V, Freson K, Thys C, Wittevrongel C, Hoylaerts MF, De Vos R, Goemans N, van Geet C. Increased GS signalling in platelets and impaired collagen activation, due to a defect in the dystrophin gene, result in increased blood loss during spinal surgery. Hum Mol Genet 2008, 17:357-66.
18. Magro A, Bizios R, Catalfamo J, Blumenstock F, Rudofsky U. Collagen-induced rat platelet reactivity is enhanced in whole blood in both the presence and absence of dense granule secretion. Thromb Res 1992, 68:345-56.
19. Kinugasa T, Uchida K, Kadowaki M, Takase H, Nomura Y, Saito Y. Effect of bile duct ligation on bile acid metabolism in rats. J Lipid Res 1981, 22:201-7.
20. Forrest EH, Dillon JF, Campbell TJ, Newsome PN, Hayes PC. Platelet basal cytosolic calcium: the influence of plasma factors in cirrhosis. J Hepatol 1996, 25:312-15.
21. Baele G, Beke R, Barbier F. In vitro inhibition of platelet aggregation by bile salts. Thromb Haemost 1980, 44:62-4.
22. Pietrapiana D, Sala M, Prat M, Sinigaglia F. Met identification on human platelets: role of hepatocyte growth factor in the modulation of platelet activation. FEBS Lett 2005, 579:4550-4.
23. Essex DW, Li M. Redox control of platelet aggregation. Biochemistry 2003, 42:129-36.
24. Zimmermann H. Two novel families of ectonucleotidases: molecular structures, catalytic properties and a search for function. Trends Pharmacol Sci 1999, 20:231-6.
25. Heptinstall S, Johnson A, Glenn JR, White AE. Adenine nucleotide metabolism in human blood - important roles for leukocytes and erythrocytes. J Thromb Haemost 2005, 3:2331-9.
26. Atkinson B, Dwyer K, Enjyoji K, Robson SC. Ecto-nucleotidases of the CD39/NTPdase family modulate platelet activation and thrombus formation: potential as therapeutic targets. Blood Cells Mol Dis 2006, 36:217-22.
27. Peng Z, Fernandez P, Wilder T, Yee H, Chiriboga L, Chan ESL, Cronstein BN. Ecto-5′-nucleotidase CD73-mediated extracellular adenosine production plays a critical role in hepatic fibrosis. FASEB J 2008, 22:2263-72.
28. Schlaeger R, Haux P, Kattermann R. Studies on the mechanism of the increase in serum alkaline phosphatase activity in cholestasis: significance of the hepatic bile acid concentration for the leakage of alkaline phosphatase from rat liver. Enzyme 1982, 28:3-13.
29. Deng JT, Hoylaerts MF, De Broe ME, van Hoof VO. Hydrolysis of membrane-bound liver alkaline phosphatase by GPI-PLD requires bile salts. Am J Physiol 1996, 271:G655-63.
30. Delzenne NM, Calderon PB, Taper HS, Roberfroid MB. Comparative hepatotoxicity of cholic acid, deoxycholic acid and lithocholic acid in the rat: in vivo and in vitro studies. Toxicol Lett 1992, 61:291-304.
31. Cattaneo M. The p2 receptors and congenital platelet function defects. Semin Thromb Hemost 2005, 31:168-73.